← Open Payments lookup

WILLIAM RUSHING: Open Payments

NPI 1952083370 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$636 in 34 payments from 10 companies in 2025. Trend: 2023 $184 · 2024 $579 · 2025 $636

Food & beverage: $636
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$163
E.R. Squibb & Sons, L.L.C.10$150
Lundbeck LLC5$106
Axsome Therapeutics, Inc.3$58
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$46
Alkermes, Inc.2$28
Teva Pharmaceuticals USA, Inc.1$24
Neurocrine BioSciences, Inc.1$21
Otsuka America Pharmaceutical, Inc.1$21
ABBVIE INC.1$20

Products named: INVEGA SUSTENNA, COBENFY, REXULTI, Auvelity, CAPLYTA, ABILIFY ASIMTUFII, ARISTADA, UZEDY.

Industry payments across MS — which companies pay providers there.